Published in Eur J Immunol on December 01, 1992
In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity. J Virol (2000) 1.45
Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells. Proc Natl Acad Sci U S A (1997) 1.23
Cell-invasive activity of epitope-tagged adenylate cyclase of Bordetella pertussis allows in vitro presentation of a foreign epitope to CD8+ cytotoxic T cells. Infect Immun (1995) 1.17
Induction of a polarized Th1 response by insertion of multiple copies of a viral T-cell epitope into adenylate cyclase of Bordetella pertussis. Infect Immun (2000) 0.98
Lassa fever virus peptides predicted by computational analysis induce epitope-specific cytotoxic-T-lymphocyte responses in HLA-A2.1 transgenic mice. Clin Diagn Lab Immunol (2005) 0.91
Peptide engineering allows cytotoxic T-cell vaccination against human papilloma virus tumour antigen, E6. Immunology (1995) 0.84
Induction of cytotoxic T-cell response by optimal-length peptides does not require CD4+ T-cell help. Immunology (1996) 0.81
Identification of new cytotoxic T-cell epitopes on the 38-kilodalton lipoglycoprotein of Mycobacterium tuberculosis by using lipopeptides. Infect Immun (1998) 0.80
Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med (1972) 24.43
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology (1991) 23.01
A new clinical scale for the staging of dementia. Br J Psychiatry (1982) 21.77
Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol (2001) 8.88
Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proc Natl Acad Sci U S A (1974) 5.13
Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes. J Exp Med (1973) 5.03
Bovine papilloma virus contains an activator of gene expression at the distal end of the early transcription unit. Mol Cell Biol (1983) 4.56
Lymphopenia and change in distribution of human B and T lymphocytes in peripheral blood induced by irradiation for mammary carcinoma. Lancet (1972) 4.36
Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. Proc Natl Acad Sci U S A (1975) 4.21
Clinical Dementia Rating (CDR). Psychopharmacol Bull (1988) 3.47
Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease. Neurology (1996) 3.29
Surface markers on human b and t lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations. Int J Cancer (1975) 2.81
Cellular signalling in programmed cell death (apoptosis). Immunol Today (1990) 2.64
Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro. Nature (1977) 2.58
Repression of bovine papilloma virus replication is mediated by a virally encoded trans-acting factor. Cell (1986) 2.58
Human lymphocyte subpopulations: classification according to surface markers and-or functional characteristics. Transplant Rev (1973) 2.53
Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology (1991) 2.53
Reliability of the Washington University Clinical Dementia Rating. Arch Neurol (1988) 2.48
Validation of clinical diagnostic criteria for Alzheimer's disease. Ann Neurol (1988) 2.38
A prospective study of cognitive function and onset of dementia in cognitively healthy elders. Arch Neurol (1998) 2.22
Surface markers on human B and T lymphocytes. VIII. Association between complement and Epstein-Barr virus receptors on human lymphoid cells. Scand J Immunol (1976) 2.18
Surface markers on human B and T lymphocytes. IV. Distribution of surface markers on resting and blast-transformed lymphocytes. Scand J Immunol (1974) 2.16
Killer cells: a functional comparison between natural, immune T-cell and antibody-dependent in vitro systems. J Exp Med (1976) 2.11
Evidence-based recommendations for the use of Negative Pressure Wound Therapy in traumatic wounds and reconstructive surgery: steps towards an international consensus. Injury (2011) 2.07
Calcium-dependent killing of immature thymocytes by stimulation via the CD3/T cell receptor complex. J Immunol (1989) 1.98
EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients. Int J Cancer (1976) 1.81
Selective inhibition of human T cell cytotoxicity at levels of target recognition or initiation of lysis by monoclonal OKT3 and Leu-2a antibodies. J Exp Med (1982) 1.74
Interlaboratory histopathologic assessment of Alzheimer neuropathology: different methodologies yield comparable diagnostic results. Alzheimer Dis Assoc Disord (1993) 1.72
Recycling and target binding capacity of human natural killer cells. J Exp Med (1981) 1.71
Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages. J Immunol (1987) 1.61
Epstein-Barr virus interactions with human lymphocyte subpopulations: virus adsorption, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformation. Infect Immun (1976) 1.61
Surface markers on human B and T-lymphocytes. IX. Two-color immunofluorescence studies on the association between ebv receptors and complement receptors on the surface of lymphoid cell lines. Int J Cancer (1976) 1.58
Factors associated with residents' attitudes toward dying patients. Fam Med (1999) 1.56
Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers. J Infect Dis (1990) 1.54
Obesity and complications in breast reduction surgery: are restrictions justified? J Plast Reconstr Aesthet Surg (2007) 1.51
Interleukin-10 mRNA expression in B-cell chronic lymphocytic leukaemia inversely correlates with progression of disease. Br J Haematol (1996) 1.45
Inducibility of the Epstein-Barr virus (EBV) cycle and surface marker properties of EBV-negative lymphoma lines and their in vitro EBV-converted sublines. Int J Cancer (1976) 1.41
Technology assessment revisited: does positron emission tomography have proven clinical efficacy? Neurology (1991) 1.39
Agents that elevate cAMP stimulate DNA fragmentation in thymocytes. J Immunol (1990) 1.36
Sensitization of human lymphocytes against autologous or allogeneic lymphoblastoid cell lines: characteristics of the reactive cells. Scand J Immunol (1974) 1.35
The activity and signaling range of mature BMP-4 is regulated by sequential cleavage at two sites within the prodomain of the precursor. Genes Dev (2001) 1.33
Evidence-based recommendations for negative pressure wound therapy: treatment variables (pressure levels, wound filler and contact layer)--steps towards an international consensus. J Plast Reconstr Aesthet Surg (2011) 1.33
Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes. Clin Exp Immunol (1975) 1.31
Human spontaneous killer cells selective for tumour-derived target cells. Nature (1978) 1.30
Self-replicating Semliki Forest virus RNA as recombinant vaccine. Vaccine (1994) 1.30
In vitro studies of lymphocytes from patients with plasma cell myeloma. II. Characterization by cell surface markers. Clin Exp Immunol (1973) 1.26
Polyunsaturated free fatty acids stimulate an increase in cytosolic Ca2+ by mobilizing the inositol 1,4,5-trisphosphate-sensitive Ca2+ pool in T cells through a mechanism independent of phosphoinositide turnover. J Biol Chem (1990) 1.26
The bovine papillomavirus replicon. Ciba Found Symp (1986) 1.22
Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus. Proc Natl Acad Sci U S A (1995) 1.21
In vitro induction of cytotoxic effector cells with spontaneous killer cell specificity. J Exp Med (1978) 1.19
A molecular analysis of hyalin--a substrate for cell adhesion in the hyaline layer of the sea urchin embryo. Dev Biol (1998) 1.18
Inhibition of DNA fragmentation in thymocytes and isolated thymocyte nuclei by agents that stimulate protein kinase C. J Biol Chem (1989) 1.17
IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages. Clin Exp Immunol (1988) 1.16
Mild senile dementia of Alzheimer type: research diagnostic criteria, recruitment, and description of a study population. J Neurol Neurosurg Psychiatry (1982) 1.11
Analysis of the prion protein gene in thalamic dementia. Neurology (1992) 1.09
Identification of amino acids in the V3 region of gp120 critical for virus neutralization by human HIV-1-specific antibodies. Immunology (1991) 1.09
Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis. Clin Exp Immunol (1976) 1.09
In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides. J Immunol Methods (1992) 1.08
Immunization with glycosylated Kb-binding peptides generates carbohydrate-specific, unrestricted cytotoxic T cells. Eur J Immunol (1996) 1.08
Effect of pre- and postmortem variables on specific mRNA levels in human brain. Brain Res Mol Brain Res (1991) 1.07
Adult idiopathic communicating hydrocephalus with and without shunting. J Neurol Neurosurg Psychiatry (1978) 1.06
Facilitating quality improvement in primary health care by practice visiting. Qual Health Care (1998) 1.06
Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells. J Immunol (1991) 1.05
Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia. Br J Cancer (2007) 1.05
SRBC rosette formation as a human T lymphocyte marker. Scand J Immunol (1976) 1.05
The expression of human natural killer cell receptors in early life. Scand J Immunol (2007) 1.04
Killer T cells in a Burkitt's lymphoma biopsy. Nature (1975) 1.04
TAP2-defective RMA-S cells present Sendai virus antigen to cytotoxic T lymphocytes. Eur J Immunol (1993) 1.03
CD6 ligation modulates the Bcl-2/Bax ratio and protects chronic lymphocytic leukemia B cells from apoptosis induced by anti-IgM. Blood (1997) 1.02
Growth inhibition of new human thyroid carcinoma cell lines by activation of adenylate cyclase through the beta-adrenergic receptor. J Clin Endocrinol Metab (1997) 1.01
Crystal structure of an MHC class I presented glycopeptide that generates carbohydrate-specific CTL. Immunity (1999) 1.00
Production of T-cell cytokines at the single-cell level in patients with inflammatory arthritides: enhanced activity in synovial fluid compared to blood. Br J Rheumatol (1998) 1.00
Psychometric differentiation of mild senile dementia of the Alzheimer type. Arch Neurol (1984) 0.99
Antitumor actions of cytokines on new human papillary thyroid carcinoma cell lines. J Clin Endocrinol Metab (1996) 0.99
Transcription and post-transcriptional regulation of avian HSP70 gene expression. J Biol Chem (1986) 0.99
Predictive features in mild senile dementia of the Alzheimer type. Neurology (1984) 0.99
Evidence-based recommendations for the use of negative pressure wound therapy in chronic wounds: steps towards an international consensus. J Tissue Viability (2011) 0.98
Expression and transcriptional regulation of functionally distinct Bmf isoforms in B-chronic lymphocytic leukemia cells. Leukemia (2004) 0.98
Influence of IgG and IgM receptor triggering on human natural killer cell cytotoxicity measured on the level of the single effector cell. Eur J Immunol (1981) 0.98
Detection of antibodies which mediate human immunodeficiency virus-specific cellular cytotoxicity (ADCC) in vitro. J Immunol Methods (1987) 0.98
Effect of ligand-activated estrogen receptor β on lymphoma growth in vitro and in vivo. Leukemia (2011) 0.98
Cross-national interrater reliability of dementia diagnosis in the elderly and factors associated with disagreement. Neurology (1996) 0.97
Interleukin 1 inhibits T cell receptor-mediated apoptosis in immature thymocytes. J Biol Chem (1990) 0.97
Preliminary report on affective symptoms in the early stages of senile dementia of the Alzheimer type. Am J Psychiatry (1983) 0.96
Monolayer immune complex (MIC) fractionation of Fc receptor bearing human spontaneous killer cells. J Immunol Methods (1978) 0.96
Somatic cell hybrids between human lymphoma lines. III. Surface markers. Int J Cancer (1977) 0.96
Diagnostic implication of specific immunoglobulin G patterns of children born to HIV-infected mothers. AIDS (1989) 0.96
Cellular signaling in thymocyte apoptosis. Semin Immunol (1992) 0.96
Referral notes used as a tool for evaluating the co-operation between general practitioners and hospital physicians. Scand J Prim Health Care (1994) 0.95
Heat-inactivated Sendai virus can enter multiple MHC class I processing pathways and generate cytotoxic T lymphocyte responses in vivo. J Immunol (1995) 0.95
Tumor infiltrating lymphocytes. Ann N Y Acad Sci (1976) 0.95
Clinical Dementia Rating. Br J Psychiatry (1984) 0.95
Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients. Clin Exp Immunol (1989) 0.95
Ca2+ entry in T cells is activated by emptying the inositol 1,4,5-triphosphate sensitive Ca2+ pool. Cell Calcium (1991) 0.95
Surface markers on human B and T lymphocytes. VII. Rosette formation between peripheral T lymphocytes and lymphoblastoid B-cell lines. Scand J Immunol (1975) 0.94